Authors


Joseph Friedman, RPh, MBA

Latest:

Should you establish a medical marijuana dispensary?

If your inner entrepreneur is hollering to get out, maybe you should go for it.



Peter A. Kreckel, RPh

Latest:

Pharmacists Provide Harm Reduction Services to Patients With Substance Use Disorder

Our whole country needs to do better in providing harm reduction services, including naloxone and syringe service programs.


Perry Cohen, PharmD, FAMCP

Latest:

It's Time for Pharmacists to Carve Out a New Role

Specialty pharmaceuticals will have a growing impact on pharmacists. Here’s how it could change your role.


Susan Egbert

Latest:

Patients and Herbal Supplements

Your patients are using herbal products, but do you know enough about them?


David Stanley, RPh

Latest:

Hold the phone

How can an independent pharmacy survive in the face of competition from the mega-chains? Here's a clue.


John Schieszer, MA

Latest:

Barriers Coming Down for Complex Generic Drug Products

This year may mark a dramatic difference in the development and approval of complex generic drug products.


Jeff Cineas, PharmD Candidate

Latest:

Apalutimide for Prostate Cancer: What to Know

FDA approves apalutamide for castration-resistant prostate cancer.


Stephanie Trexler, PharmD Candidate

Latest:

Apalutimide for Prostate Cancer: What to Know

FDA approves apalutamide for castration-resistant prostate cancer.


Dustyn Williams, MD

Latest:

Diabetes Management and the Promise of Telemedicine

Could telemedicine be the answer to diabetes management problems?


Zoe Barry

Latest:

Fixing a Broken System with Technology

Technology can help patients who need specialty pharmacy medications get them faster by streamlining the processes involved.


Paul Armentano

Latest:

Making the Case for Regulated Marijuana

Pharmacists urged to support controls to the marijuana market but oppose criminalization.


Anita Siu, PharmD, BCPPS

Latest:

Pediatric Patients Present Unique Challenges to Pharmacists

Board-certified pharmacists are better prepared to deal with pediatric patients than others. Here’s why.


Gianna Casal, PharmD

Latest:

Betrixaban for Prophylaxis of Venous Thromboembolism

Betrixaban has been approved by the FDA for patients at risk for thromboembolisms. 


Matthew Davis, PharmD

Latest:

Betrixaban for Prophylaxis of Venous Thromboembolism

Betrixaban has been approved by the FDA for patients at risk for thromboembolisms. 


Deepak Thomas

Latest:

Four Things Pharmacists Need to Know About Specialty Pharmacy

How independent pharmacies can use specialty medications to increase profits and help their patients. 


David Pope, PharmD, CDE

Latest:

Let’s Do This! A Call to Action for Test to Treat in Pharmacy

President Biden’s recent State of the Union address included a pharmacy Test to Treat iniativie for COVID-19.


David Smith, RPh

Latest:

What Community Pharmacists Want-And How You Can Get It

NCPA found three things that pharmacists desperately want changed. Here’s how they’re going to do it.


James A Jorgenson, RPh, MS

Latest:

Pharmacists, It’s Time to Speak Up

Healthcare is at a dangerous place right now-but pharmacists can be the ones to help save it.


Tyree H. Kiser, Pharm D.

Latest:

Critical Care Board Certification Gains Momentum

If you’ve never thought about becoming certified, now is a great time to do it.


Chuck Green

Latest:

The Smart Technology That Will Change Diabetes Care

GPS-based dietary prompts, continuous glucose monitors among the devices poised to revolutionize diabetes treatment and patient management. 


John Lindsley, PharmD, BCPS-AQ Cardiology

Latest:

How Pharmacists Can Tackle the Leading Cause of Death

Interested in cardiology? Here’s why you should consider becoming extra training and certification.



Joseph L Lee PharmD, MPH Candidate 2019

Latest:

Why Pharmacists Need to Change Their Attitude

The opioid epidemic requires that all healthcare professionals-pharmacists included-re-examine how they approach pain patients.


Shyam Patel, PharmD

Latest:

New Drug Review: Spravato

Both responder and remitter patients experienced a statistically significant longer time to relapse with esketamine compared to the placebo


Lindsey M. Childs-Kean, PharmD, MPH, BCPS

Latest:

Advances in Hepatitis C Treatment

This peer-reviewed article will show you what you need to know about the latest breakthroughs and treatment options.


Kevin Deemer, PharmD

Latest:

Advances in Hepatitis C Treatment

This peer-reviewed article will show you what you need to know about the latest breakthroughs and treatment options.


Carlos Madruga, PharmD

Latest:

Advances in Hepatitis C Treatment

This peer-reviewed article will show you what you need to know about the latest breakthroughs and treatment options.


Allan Ginsberg, RPh, MHA, CMTM

Latest:

Why I Still Recommend the Pharmacist Profession

Pharmacy has changed a lot in the last 50 years-but a lot of that has been for the good of the profession and the public.


Jennifer Gershman, PharmD, CPh

Latest:

On Cystic Fibrosis Multidisciplinary Care Teams, Pharmacists Are Vital

Pharmacists are essential for managing complex CF regimens, monitoring their effectiveness, and improving adherence.

© 2025 MJH Life Sciences

All rights reserved.